Beressa Tamirat Bekele, Deyno Serawit, Mtewa Andrew G, Aidah Namuli, Tuyiringire Naasson, Lukubye Ben, Weisheit Anke, Tolo Casim Umba, Ogwang Patrick Engeu
Department of Pharmacy, College of Medicine and Health Sciences, Ambo University, Ambo, Ethiopia.
Pharm-Biotechnology and Traditional Medicine Center of Excellence, Mbarara University of Science and Technology, Mbarara, Uganda.
Front Pharmacol. 2021 Dec 24;12:682794. doi: 10.3389/fphar.2021.682794. eCollection 2021.
Viruses cause various human diseases, some of which become pandemic outbreaks. This study synthesized evidence on antiviral medicinal plants in Africa which could potentially be further studied for viral infections including Coronavirus disease 2019 (COVID-19) treatment. PUBMED, CINAHIL, Scopus, Google Scholar, and Google databases were searched through keywords; antiviral, plant, herb, and Africa were combined using "AND" and "OR". studies, studies, or clinical trials on botanical medicine used for the treatment of viruses in Africa were included. Thirty-six studies were included in the evidence synthesis. Three hundred and twenty-eight plants were screened for antiviral activities of which 127 showed noteworthy activities against 25 viral species. These, were Poliovirus (42 plants), HSV (34 plants), Coxsackievirus (16 plants), Rhinovirus (14plants), Influenza (12 plants), Astrovirus (11 plants), SARS-CoV-2 (10 plants), HIV (10 plants), Echovirus (8 plants), Parvovirus (6 plants), Semiliki forest virus (5 plants), Measles virus (5 plants), Hepatitis virus (3 plants), Canine distemper virus (3 plants), Zika virus (2 plants), Vesicular stomatitis virus T2 (2 plants). Feline herpesvirus (FHV-1), Enterovirus, Dengue virus, Ebola virus, Chikungunya virus, Yellow fever virus, Respiratory syncytial virus, Rift Valley fever virus, Human cytomegalovirus each showed sensitivities to one plant. The current study provided a list of African medicinal plants which demonstrated antiviral activities and could potentially be candidates for COVID-19 treatment. However, all studies were preliminary and screening. Further are required for plant-based management of viral diseases.
病毒会引发各种人类疾病,其中一些会演变成大流行疫情。本研究综合了非洲抗病毒药用植物的相关证据,这些植物可能值得进一步研究用于包括2019冠状病毒病(COVID - 19)治疗在内的病毒感染。通过关键词在PUBMED、CINAHIL、Scopus、谷歌学术和谷歌数据库中进行搜索;使用“AND”和“OR”组合“抗病毒”“植物”“草药”和“非洲”等关键词。纳入了关于非洲用于治疗病毒的植物药的研究、研究报告或临床试验。证据综合纳入了36项研究。筛选了328种植物的抗病毒活性,其中127种对25种病毒表现出显著活性。这些病毒包括脊髓灰质炎病毒(42种植物)、单纯疱疹病毒(34种植物)、柯萨奇病毒(16种植物)、鼻病毒(14种植物)、流感病毒(12种植物)、星状病毒(11种植物)、严重急性呼吸综合征冠状病毒2(SARS-CoV-2,10种植物)、人类免疫缺陷病毒(HIV,10种植物)、艾柯病毒(8种植物)、细小病毒(6种植物)、塞姆利基森林病毒(5种植物)、麻疹病毒(5种植物)、肝炎病毒(3种植物)、犬瘟热病毒(3种植物)、寨卡病毒(2种植物)、水疱性口炎病毒T2(2种植物)。猫疱疹病毒(FHV - 1)、肠道病毒、登革病毒、埃博拉病毒、基孔肯雅病毒、黄热病毒、呼吸道合胞病毒、裂谷热病毒、人类巨细胞病毒每种都对一种植物敏感。本研究提供了一份显示具有抗病毒活性的非洲药用植物清单,这些植物有可能成为COVID - 19治疗的候选药物。然而,所有研究都是初步的且需要进一步筛选。基于植物的病毒病管理还需要进一步研究。